Braveheart Bio, Inc. ($BRVE)
Filing Information
| Accession Number | 0001193125-26-340528 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
95,723,287
Total Value
$64,800,000.00
P&L
+38.9% (+$25,236,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 7, 2026 | Conversion | 9,132,420 | $0.00 | $0.00 | 9,720,546 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 7, 2026 | Conversion | 7,990,867 | $0.00 | $0.00 | 8,505,478 | Indirect | By Forbion Ventures Fund VII Cooperatief U.A. | View Details | |
10% Owner | Common Stock | โ | Aug 7, 2026 | Purchase | 1,920,000 | $18.00 | $34,560,000.00 | 11,640,546 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 7, 2026 | Purchase | 1,680,000 | $18.00 | $30,240,000.00 | 10,185,478 | Indirect | By Forbion Ventures Fund VII Cooperatief U.A. | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Aug 7, 2026 | Conversion | 40,000,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Aug 7, 2026 | Conversion | 35,000,000 | $0.00 | $0.00 | 0 | Indirect | By Forbion Ventures Fund VII Cooperatief U.A. | View Details |